Skip to main content
. 2017 Apr 27;25(6):1316–1327. doi: 10.1016/j.ymthe.2017.03.035

Table 1.

Biodistribution of H10 mRNA in Plasma and Tissue after IM Administration in Mice

Matrix tmax (hr) Cmax (ng/mL)
AUC0–264 h (ng.hr/mL)
t1/2 (h)
Mean SE Mean SE
Bone marrow 2.0 3.35 1.87 NA NC
Brain 8.0 0.429 0.0447 13.9 1.61 NR
Cecum 8.0 0.886 0.464 11.1 5.120 NC
Colon 8.0 1.11 0.501 13.5 5.51 NC
Distal lymph nodes 8.0 177.0 170.0 4,050 2,060 28.0
Heart 2.0 0.799 0.225 6.76 1.98 3.50
Ileum 2.0 3.54 2.60 22.6 10.8 5.42
Jejunum 2.0 0.330 0.120 5.24 0.931 8.24
Kidney 2.0 1.31 0.273 9.72 1.44 11.4
Liver 2.0 47.2 8.56 276 37.4 NC
Lung 2.0 1.82 0.555 12.7 2.92 16.0
Muscle (injection site) 2.0 5,680 2,870 95,100 20,000 18.8
Plasma 2.0 5.47 0.829 35.5 5.41 9.67
Proximal lymph nodes 8.0 2,120 1,970 38,600 22,000 25.4
Rectum 2.0 1.03 0.423 14.7 3.67 NR
Spleen 2.0 86.9 29.1 2,270 585 25.4
Stomach 2.0 0.626 0.121 11.6 1.32 12.7
Testes 8.0 2.37 1.03 36.6 11.8 NR

Male CD-1 mice received 300 μg/kg (6 μg) formulated H10 mRNA via IM immunization. Two replicates of bone marrow, lung, liver, heart, right kidney, inguinal- and popliteal-draining lymph nodes, axillary distal lymph nodes, spleen, brain, stomach, ileum, jejunum, cecum, colon, rectum, testes (bilateral), and injection site muscle were collected for bDNA analysis at 0, 2, 8, 24, 48, 72, 120, 168, and 264 hr after dosing (n = 3 mice/time point). NA, not applicable AUC with less than three quantifiable concentrations; NC, not calculated; NR, not reported because extrapolation exceeds 20% or R-squared is less than 0.80.